BioNTech SE Alternatives & Competitors

12 companies similar to BioNTech SE — Our vision is to harness the power of the immune system to develop novel therapi...

PMV Pharmaceuticals, Inc.

Harnessing the power of p53 to treat cancer

70 Series D $236.00M

Princeton, United States

Biopharma Biotechnology +2

Mosaic TX

Resolving cancer's complexity through the power of targeted drug combinations

22 Series A $28.52M

United Kingdom

Biotechnology Health and Wellness

Breakpoint Therapeutics

Modulating DNA damage responses to cure cancer

3 Series Unknown $30.00M

Hamburg, Germany

Biotechnology Health Care +1

KSQ Therapeutics, Inc.

The company is deploying CRISPRomics for novel drug development across broad therapeutic a...

60 Series C $166.00M

Lexington, United States

Biopharma Biotechnology +2

Track all BioNTech SE competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

OnCusp Therapeutics

We Bring Oncology Innovation to Life

28 Series A $125.00M

New York, United States

Biotechnology Health Care +1

RayzeBio

Targeted innovative radiopharmaceuticals for cancer

258 Acquired $4.78B

San Diego, United States

Biotechnology Health Care +2

Crossbow Therapeutics, Inc

Established antibody engineering to target the untapped universe of intracellular cancer t...

45 Series B $157.00M

Cambridge, United States

Biotechnology Health Care +1

RNAimmune

Novel medicine for all through mRNA therapeutics.

9 Series A $39.35M

Gaithersburg, United Stat...

Biotechnology Health Care +1

Hummingbird Bioscience

Hummingbird Bioscience is a precision biotherapeutics company discovering and developing t...

82 Series C $150.00M

Singapore, Singapore

Biotechnology Health Care +1

Lif – de forskande läkemedelsföretagen

Lif är en branschorganisation som arbetar för god tillgång till nya behandlingar och en st...

Stockholm, Sweden

Biotechnology Pharmaceutical

Affini-T Therapeutics

Right Targets. Right Cells. Right Place. Unlocking the power of T cells against oncogenic...

11 Series Unknown $175.00M

Watertown, United States

Biotechnology Health Care +1

Granza Bio

Reprogramming Immunity for Target-Specific Medicines

7 Seed $7.64M

Biopharma Biotechnology +1

About BioNTech SE

Our vision is to harness the power of the immune system to develop novel therapies against cancer & infectious diseases.

Services

Development of immunotherapies, mRNA vaccine development, Oncology treatment advancement, Research & Innovation

Target Customers

Cancer patients, Medical professionals, Healthcare institutions, Research collaborators

Taxonomy

Immunotherapy, MRNA Therapeutics, Oncology, Individualized Cancer Medicine, Patient-specific Immunotherapy, CAR T Cells, Bispecific Antibodies, Antibody-drug Conjugates, Small Molecule Immunomodulators, Infectious Diseases, Cell Therapy, Protein-based Therapeutics, Chimeric Antigen Receptor

Business Model

B2B, B2C, B2D

Revenue Model

Product Sales, Licensing, Service Fee

Frequently Asked Questions

Top alternatives to BioNTech SE include PMV Pharmaceuticals, Inc., Mosaic TX, Breakpoint Therapeutics, KSQ Therapeutics, Inc., OnCusp Therapeutics. These companies serve similar markets and are frequently compared.

Bounce Watch tracks 12 companies similar to BioNTech SE based on industry overlap, target customers, and business model.

Our vision is to harness the power of the immune system to develop novel therapies against cancer & infectious diseases.

Don't just read about them. Follow them.

BounceWatch watches BioNTech SE and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

BioNTech SE Profile PMV Pharmaceuticals, Inc. Alternatives Mosaic TX Alternatives Breakpoint Therapeutics Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at BioNTech SE on 19 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.